IE 11 is a very old Browser and it`s not supported on this site

Group structure and shareholders

Corporate structure as December 31, 2022

Source: Bellevue Group, as of December 31, 2022

Scope of consolidation

Bellevue Group AG is the only listed company within the Group. The investment companies we manage, BB Biotech AG and Bellevue Healthcare Trust, are independent companies listed on their respective stock exchanges. The companies consolidated by Bellevue Group are listed, together with information regarding their domicile and share capital and the interest held by the Group, in the notes to the consolidated financial statements, note 6 «Major subsidiaries».

Major shareholders

Based on the notifications received and published by Bellevue Group AG, the following parties hold significant voting rights:

Shareholder or beneficial owner

 

31.12.2022 Voting rights held

 

31.12.2022 Number of shares held

 

31.12.2021 Voting rights held

 

31.12.2021 Number of shares held

Martin Bisang, Küsnacht

 

20.43%

 

2 750 000

 

20.43%

 

2 750 000

Hans Jörg Wyss, Cambridge MA (USA)

 

9.66%

 

1 300 000

 

9.66%

 

1 300 000

Jürg und Manuela Schäppi, Rapperswil-Jona

 

9.05%

 

1 217 799

 

9.05%

 

1 217 799

The shareholders Martin Bisang (Küsnacht), as well as Jürg and Manuela Schäppi (Jona) signed a shareholder agreement on October 25, 2018. Martin Bisang will represent the Group and controls 29.48% of the voting rights by December 31, 2022 (December 31, 2021: 29.48%).

Disclosure notifications are retrievable from the SIX Swiss Exchange website at: https://www.ser-ag.com/en/resources/notifications-market-participants/significant-shareholders.html#/

Cross-shareholdings

There are no cross-shareholdings between Bellevue Group AG or its subsidiaries and other corporations.

Bellevue Group uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer